Scancell (LON:SCLP) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

Shares of Scancell Holdings plc (LON:SCLP) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 12.24 ($0.16) and traded as low as GBX 8.10 ($0.11). Scancell shares last traded at GBX 8.50 ($0.11), with a volume of 329,311 shares.

Scancell Stock Up 0.6 %

The firm’s fifty day moving average is GBX 9.15 and its two-hundred day moving average is GBX 12.24. The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The firm has a market cap of £88.04 million, a price-to-earnings ratio of -13.03 and a beta of 0.35.

Scancell (LON:SCLP) last released its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. On average, sell-side analysts expect that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.